Registration Options

Activity Date: 04/26/2022

Session Time and Location

The live session is complete.

Target Audience

If you are a pharmacist, nurse practitioner, or other health care professional providing comprehensive medication management for individuals living with psychiatric disorders, we invite you to participate in this course.

Session Summary

ADHD medication use among women of reproductive age has increased dramatically in recent years. Understanding both the risks of untreated symptoms and the risks of medications can inform treatment decisions that reduce risks. In this session, we’ll review gender influences on the presentation of ADHD, ADHD risks relevant to pregnancy, and a systematic approach to risk assessment. Through illustrative composite cases, we’ll compare risks of untreated symptoms to risks of medications for ADHD and some of its common comorbidities. We’ll discuss the role of nonpharmacologic interventions for ADHD. We’ll examine how risk/benefit analyses can change with the transition to motherhood, including considerations for women who are breastfeeding.

Course Requirements

To receive ACPE credit for this session, you must:

  • Sign in (or create a FREE account).
  • Register for this course.
  • Review the full content of the activity and reflect upon its teachings.
  • Complete the post-test at the end of the activity no later than the closing activity date.
  • Complete the evaluation at the end of the activity.
  • If necessary, complete the post-test retest no later than the closing activity date.
  • Receive a passing grade (70%).
  • Provide the necessary details in your profile to ensure correct reporting by CPNP to CPE Monitor.
Upon successful completion, ACPE credit is reported within 24 hours to CPE Monitor although transcripts can be retrieved by participants online in their ACPE Transcript.

Faculty Information and Disclosures

Learning Objectives

  1. Explain how to frame decisions about perinatal treatment of ADHD.
  2. List at least three risks of untreated ADHD that are relevant to pregnancy.
  3. Explain perinatal risks associated with commonly used ADHD medications.
  4. Describe how the risk/benefit analysis for use of ADHD medication can change postpartum.

Continuing Education Credit and Disclosures

Activity Date: 04/26/2022
ACPE Contact Hours: 1
ACPE Number: 0284-0000-22-048-H04-P (Knowledge)
Nursing Credit Reminder: Note that ACPE credit is accepted for certification renewal.

ACPEThe College of Psychiatric and Neurologic Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

25 Years!